
    
      PROTOCOL OUTLINE: This is a randomized, investigator-blinded, placebo-controlled study.

      Patients receive a single dose of either collagenase or placebo into the target finger on day
      0. Patients who do not respond at the 1 month follow up visit may receive an injection of
      open label collagenase, if IgE antibody levels are no greater than 15 ng/mL.

      Following treatment, patients use a nighttime extension splint for 4 months and perform
      finger flexion/extension exercises. Patients are followed at 1, 7, and 14 days, and at 1, 2,
      3, 6, 9, and 12 months, for each joint treated.

      Completion date provided represents the completion date of the grant per OOPD records
    
  